Literature DB >> 11902714

PilC of pathogenic Neisseria is associated with the bacterial cell surface.

M Rahman1, H Källström, S Normark, A B Jonsson.   

Abstract

Adherence of pathogenic Neisseria to target host cells is mediated by pili. PilC1 and PilC2 are two high-molecular-weight proteins involved in pilus assembly and cellular adherence functions of the pili. Inactivation of pilC1 or pilC2 in N. meningitidis resulted in clones that expressed the same number of pili as the parent, contained no alterations in pilE and showed no detectable differences in PilE glycosylation. However, the PilC2+ pilC1- mutant showed much reduced adherence to target cells, indicating that production of PilC1 is essential for pilus-mediated adherence. To study further the functional differences between the meningococcal pilC genes, we determined the complete nucleotide sequence of pilC1 and pilC2 of N. meningitidis. Alignment of six PilC sequences demonstrated that PilC is composed of both conserved and variable regions. By immunogold labelling of bacterial sections we showed that PilC is present in the membranes of both piliated and non-piliated bacteria. Further, we demonstrated that PilC is associated with the bacterial cell surface.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 11902714     DOI: 10.1046/j.1365-2958.1997.4601823.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  47 in total

1.  The meningococcal PilT protein is required for induction of intimate attachment to epithelial cells following pilus-mediated adhesion.

Authors:  C Pujol; E Eugène; M Marceau; X Nassif
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Type IV pilus retraction in pathogenic Neisseria is regulated by the PilC proteins.

Authors:  Philippe C Morand; Emmanuelle Bille; Sandrine Morelle; Emmanuel Eugène; Jean-Luc Beretti; Matthew Wolfgang; Thomas F Meyer; Michael Koomey; Xavier Nassif
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

3.  Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37.

Authors:  Allison Jones; Miriam Geörg; Lisa Maudsdotter; Ann-Beth Jonsson
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

4.  Vaccines against gonorrhea: current status and future challenges.

Authors:  Ann E Jerse; Margaret C Bash; Michael W Russell
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

5.  Cytotoxic effects of Kingella kingae outer membrane vesicles on human cells.

Authors:  R Maldonado; R Wei; S C Kachlany; M Kazi; N V Balashova
Journal:  Microb Pathog       Date:  2011-04-02       Impact factor: 3.738

6.  Modulation of gonococcal piliation by regulatable transcription of pilE.

Authors:  C D Long; S F Hayes; J P van Putten; H A Harvey; M A Apicella; H S Seifert
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

7.  Soluble pilin of Neisseria gonorrhoeae interacts with human target cells and tissue.

Authors:  A Rytkönen; L Johansson; V Asp; B Albiger; A B Jonsson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Calcium binding properties of the Kingella kingae PilC1 and PilC2 proteins have differential effects on type IV pilus-mediated adherence and twitching motility.

Authors:  Eric A Porsch; Michael D L Johnson; Angela D Broadnax; Christopher K Garrett; Matthew R Redinbo; Joseph W St Geme
Journal:  J Bacteriol       Date:  2012-12-14       Impact factor: 3.490

9.  Role of glycosylation at Ser63 in production of soluble pilin in pathogenic Neisseria.

Authors:  M Marceau; X Nassif
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

10.  Suppression of an absolute defect in type IV pilus biogenesis by loss-of-function mutations in pilT, a twitching motility gene in Neisseria gonorrhoeae.

Authors:  M Wolfgang; H S Park; S F Hayes; J P van Putten; M Koomey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.